LABRHA participated in the 17th EULAR Congress which took place from the 8th to the 11th of June 2016 in London. 1) Predictive factors of failure of viscosupplementation in patients with knee Osteoarthritis. Results of a post-hoc analysis of a double blind, controlled non Inferiority trial. F. Eymard, T. Conrozier, Read more…
LABRHA participated in the last OARSI Congress which took place from the 31st of March to the 3rd of April 2016 in Amsterdam. The company presented the results of the double-blind, controlled, multicenter, randomized trial conducted on 226 patients and comparing the efficacy and tolerance of HAppyVisc® vs. Euflexxa®. Read more…
LABRHA participated in the 3rd International Symposium on Intra-Articular Treatment (ISIAT) Congress which took place in Budapest last 1-3 October 2015. The following 4 oral communications were presented for the company by Dr. Thierry Conrozier: Safety and efficacy of intra articular injections of a combination of hyaluronic acid and mannitol Read more…
LABRHA actively participated in the 27th Annual Congress of the French Society of Rheumatology which took place in Paris from 7 to 9 December 2014. LABRHA was present with a booth in the exhibition area (F4-F5) where the company’s innovative portfolio and scientific projects were presented to the medical community. Read more…
Before publication in a peer-reviewed journal, we communicate and present our work and research findings at important scientific meetings and medical conferences. Several research abstracts have already been displayed and presented on oversized posters at different meetings. Please find them below: CUIVRAMINE DIFFERENTIAL IMPACT OF GLUCOSAMINE SULFATE AND CUIVRAMINE® ON Read more…